| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.999 | 132.374 | 163.679 | 151.169 | 140.734 | 167.083 | 495.244 | 467.703 | 448.040 | 323.845 |
| Total Income - EUR | 48.999 | 132.376 | 164.123 | 151.346 | 140.765 | 167.083 | 495.244 | 467.703 | 449.743 | 326.067 |
| Total Expenses - EUR | 38.979 | 56.006 | 59.584 | 73.166 | 77.794 | 110.534 | 243.358 | 335.877 | 206.594 | 203.523 |
| Gross Profit/Loss - EUR | 10.020 | 76.370 | 104.538 | 78.181 | 62.971 | 56.549 | 251.886 | 131.825 | 243.148 | 122.545 |
| Net Profit/Loss - EUR | 8.550 | 69.433 | 99.749 | 76.623 | 61.564 | 55.846 | 246.372 | 127.242 | 239.843 | 113.667 |
| Employees | 0 | 1 | 0 | 2 | 2 | 2 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Totir Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.807 | 16.528 | 71.597 | 106.106 | 86.852 | 63.239 | 66.829 | 63.292 | 85.588 | 68.541 |
| Current Assets | 15.973 | 63.335 | 110.956 | 19.457 | 64.062 | 92.616 | 198.333 | 205.959 | 271.349 | 222.251 |
| Inventories | 1.209 | 1.481 | 6.103 | 3.136 | 2.723 | 14.958 | 36.214 | 4.397 | 28.176 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 126.656 | 52.550 | 52.914 |
| Cash | 14.764 | 61.854 | 104.853 | 16.321 | 61.340 | 77.658 | 162.119 | 74.906 | 190.623 | 169.336 |
| Shareholders Funds | 18.572 | 69.486 | 99.801 | 76.675 | 61.614 | 116.292 | 246.420 | 127.290 | 249.269 | 271.981 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 208 | 10.377 | 83.069 | 48.888 | 89.300 | 39.562 | 18.741 | 141.960 | 107.668 | 18.810 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Totir Medica Srl